Speakers

Adam Taylor

Scientist

Defence Science & Technology Laboratory - DSTL

Agnieska Czechowicz

Assistant Professor of Pediatrics

Stanford University School of Medicine

Alain Beck

Senior Director, Biologics CMC & developability

Pierre Fabre

Anand Subramony

Vice President, Antibody Discovery & Protein Engineering, R&D

AstraZeneca

Andre Dumetz

Senior Scientific Investigator

GlaxoSmithKline

Andreas Pahl

Chief Scientific Officer

Heidelberg Pharma

Arturo Molina

Chief Medical Officer

Sutro Biopharma

Audrey Bendelac

ADC scientific manager, process development

Sanofi

Bob Bayer

Director of CMC Drug Development

Tanabe Research Laboratories

Bob Liu

Senior Scientist

CytomX

Brian Lannutti

Senior Vice President - Research & Development

Velosbio

Christopher Scott

Professor - Pharmaceutical Biosciences

Queen's University Belfast

David Newman

Independent Consultant

David Thurston

Chief Scientific Officer

Femtogenix

Donald Mager

Professor & Vice Chair of Pharmaceutical Sciences

University at Buffalo

Dorota Roberts

Associate Director Technical Product Steward - Biologics

Seagen

Ed Ha

Founding Principal Scientist

AngieX

Elizabeth Love

Senior Scientist - Drug conjugates, Biologics & Analysis

LifeArc

Francesca Zammarchi

Head of Pharmacology

ADC Therapeutics

Futa Mimoto

Research Manager

Chugai Pharmaceuticals

Gang Yao

Director, Head of Novel Modalities R&D

Merck

Gareth Thomas

Professor - Experimental Pathology

University of Southampton

Gavin Bennett

Director & Project Leader

Bicycle Therapeutics

Gordon Rigg

Principal Consultant

Apex Biologics Consulting

Gilles Gallant

Senior Vice President, Global Head of Oncology Development, Oncology R&D

Daiichi Sankyo

Giorgio Salciarini

Technical Business Development Manager

BSP Pharmaceuticals

Graham Cotton

Head of Protein Therapeutics

Almac Discovery

Horst Bierau

Senior Scientific Advisor – Head CMC Science & Intelligence

Merck KGaA

Ian Schwartz

Global Technology Consultant – Proteins and Bioconjugates

Sartorius

Jagath Reddy Junutula

Sr Vice President

ModMab Therapeutics

Jeff Carroll

Group Leader Process and Analytical Development

Merck

Jia He

Analyst

Beacon Target Therapies

John Harlan

Senior Principal Research Scientist

AbbVie

John Lambert

Independent Consultant

Attager Consulting

Jon Van Dyck

Sr. Scientist

Seagen

Jostein Dahle

Chief Scientific Officer

Nordic Nanovector

Justin Oh

Chief Business Officer

AbTis

Krista Kinneer

Senior Scientist

AstraZeneca

Lisa Mcdermott

Director - Process & Analytical Development

Merck

Lolke de haan

Head of Toxicology

ADC Therapeutics

Maria Laura Greco

Marie Curie Research Fellow

AstraZeneca

Marie Leman

Drug Product Team Leader & Tech Transfer Leader

Sanofi

Martyn Ryder

Director

Solo Containment

Mike Rigby

Project Leader

Bicycle Therapeutics

Nathan Ihle

Vice President - Chemistry, Manufacturing, Controls & Quality

Bolt Biotherapeutics

Nicolas Camper

Group Leader, Chemistry

Abzena

Nithyanandan Nagercoil

Expert Medical Assessor

Medicines & Healthcare Products Regulatory Agency (MHRA)

Omar Lamm

Business Development and Strategy - Biopharmaceutical Development

Merck

Paul Song

Chief Scientific Officer

GeneQuantum Healthcare

Penelope Drake

Head of R&D, Bioconjugates

Catalent

Phil Howard

Chief Scientific Officer

Spirogen

Rick Powers

Independent Consultant

Robert Straubinger

Professor of Pharmaceutical Sciences

University at Buffalo

Robert Sussman

Managing Director

SafeBridge Regulatory & Life Sciences Group

Roger Beerli

Chief Scientific Officer

NBE-Therapeutics

Rolf G. Werner

Chief Operation Officer

GeneQuantum Healthcare Co., Ltd.

Ruud Coumans

Project Leader Antibody-Drug Conjugates

Byondis

Salaheldin Hamed

Pharmacologist

FDA

Sally Ward

Director of Translational Immunology, Centre for Cancer Immunology

University of Southampton

Scott Patterson

Vice President, Technical Support

ILC Dover

Samuele Cazzamalli

Research Scientist

Philogen

Shelley Ackerman

Senior Scientist

Bolt Biotherapeutics

Signe Diness Vindeløv

Director, Medical

Genmab

Simon Chivers

Independent Consultant

Steffen Wöll

Principal Scientist

Merck

Steve Conlan

Professor

University of Swansea

Rakesh Dixit

President & Chief Executive Officer

BioNavigen

Thomas Nittoli

Director, R&D Chemistry Therapeutic Proteins

Regeneron

Toby Eyre

Haematology Consultant

Oxford University Hospitals NHS Foundation Trust

Torbjörn Gräslund

Professor in Medical Protein Technology

KTH Royal Institute of Technology

Victoria Wei

Associate Director

Johnson & Johnson

Vítor Sousa

BD Manager

Proveo

William Goundry

Principal Scientist

AstraZeneca

Zhala Tawfiq

Process Development & TT Associate Scientist

Ajinomoto Bio-Pharma Services

Full Event Guide